North America Single Cell Analysis Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)
North America Single Cell Analysis Market: by Type (Flow Cytometry, Next Generation Sequencing, PCR, Microscopy, Mass Spectrometry, Others), Application (Cancer, Neurology, Immunology, Stem Cell, Non-invasive Prenatal Diagnosis, Others), Distribution Channels (Direct Tenders, Third Party Distributors, Retail Sales, E-commerce, Others), Technology (Consumables, Instruments, Software, Services, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Last Updated: 31-07-2025 | Format: PDF | Report ID:20388
North America Single Cell Analysis Market Forecast (2020-2035)
The North America Single Cell Analysis Market is experiencing robust growth, propelled by advancements in genomics, higher prevalence of chronic diseases, and increased funding for life sciences research. With a surge in demand for personalized medicine and ongoing technological innovations in tools like flow cytometry and next-generation sequencing, the market is set to expand at a compelling pace through 2035, reflecting shifting priorities in oncology, neurology, and immunology research.
Latest Market Dynamics
Key Drivers
Rising Investments in Genomics and Life Sciences: In 2025, major funding initiatives by organizations such as the NIH continue to drive the adoption of single cell analysis. Companies like 10x Genomics exemplify commercial progress with their Chromium system, facilitating precise cell-by-cell profiling.
Growing Demand for Personalized Medicine: The increase in personalized and precision therapies, particularly in oncology, is fueling demand for detailed cellular insights. Illumina Inc. has advanced its sequencing platforms to meet the needs of clinicians and researchers in customizing patient treatments.
Key Trends
Integration of AI with Single Cell Analytics: Recent launches by companies such as Bio-Rad Laboratories highlight the adoption of artificial intelligence to streamline cell data analysis, enhancing accuracy and reducing turnaround times.
Miniaturization and Automation: The trend towards compact and automated instruments is driven by user demand for efficient laboratory workflows. Thermo Fisher Scientific introduced new benchtop solutions in early 2024 for high-throughput single cell processing.
Key Opportunities
Expansion of Clinical Applications: The emergence of single cell technologies in prenatal, immunological, and stem cell diagnostics is opening significant clinical opportunities. Beckman Coulter Inc., for example, has expanded its instrument portfolio to meet prenatal diagnostic needs.
Strategic Collaborations: Firms are increasingly partnering with biopharma companies and academic institutions to accelerate development. In June 2024, a joint research endeavor between NanoString Technologies and a leading North American cancer center was announced for advanced tumor profiling.
Key Challenges
High Cost and Technical Complexity: Despite its benefits, single cell analysis remains cost-prohibitive for smaller labs and organizations. Smaller biotech firms like Standard BioTools struggle to balance innovation with affordability.
Data Management Bottlenecks: The explosion of high-content data challenges existing digital infrastructures. Fluidigm Corporation introduced cloud-compatible storage in mid-2024 to address data scalability, but widespread adoption continues to be a hurdle.
Key Restraints
Regulatory Hurdles: Stringent regulatory approvals for new diagnostic platforms can delay market entry. Takara Bio Inc. recently encountered slower than expected FDA review for its latest single cell product.
Limited Access in Resource-Constrained Settings: Access to advanced single cell technologies remains limited outside major research and clinical hubs. Smaller hospitals and rural life sciences centers face adoption challenges, as highlighted in Merck KGaA’s 2025 customer survey.
North America Single Cell Analysis Market Share by Type (2025)
The market by type in 2025 is led by Flow Cytometry, which dominates due to its widespread applications in cell sorting and immunophenotyping. Next Generation Sequencing follows, owing to its growing utility in genomic profiling at the single-cell level. PCR-based methods also maintain a strong presence, particularly in clinical and diagnostic settings, reflecting ongoing innovation and accessibility.
North America Single Cell Analysis Market Share by Applications (2025)
By application, Cancer research remains the dominant segment, accounting for more than a third of the market in 2025. Advances in tumor profiling and liquid biopsy technologies drive this growth. Immunology holds the next largest share, reflecting increased need for immune cell profiling in research and clinical diagnostics. Neurology is also gaining ground as single cell analysis unveils novel insights into complex brain disorders.
North America Single Cell Analysis Market Revenue, 2020-2035
Market revenue for single cell analysis in North America has witnessed consistent expansion from 2020, reaching a significant milestone in 2025. The compound annual growth rate is projected to remain strong, with revenue surpassing 2,450 Million USD in 2025. This upward trajectory is driven by technology adoption, R&D investments, and expanding clinical applications, forecasting robust gains through 2035.
North America Single Cell Analysis Market YOY Growth, 2020-2035
Year-on-year growth in the single cell analysis market reflects a surge in innovation and commercialization. The market saw highest acceleration post-2022 with notable double-digit increases in 2023 and 2025. Although growth is expected to normalize slightly after 2030 as the market matures, the long-term prospects remain robust.
North America Single Cell Analysis Market by Region (% Share, 2025)
The United States clearly leads the North American market in 2025, claiming almost three-quarters of the total share, driven by its unmatched bio-research ecosystem and funding infrastructure. Canada follows, benefiting from strong research universities but facing smaller scale. Mexico represents a growing but moderate segment, gaining from expanded healthcare access and emerging industry partnerships.
Market Share by Key Players (2025)
The competitive landscape in 2025 is concentrated, with Thermo Fisher Scientific leading due to comprehensive product suites and distribution. 10x Genomics has gained considerable ground with its scalable platforms for advanced research, while BD (Becton, Dickinson and Company) and Illumina remain pivotal due to innovation and customer reach.
Market Share by Buyer Segment (2025)
Academic research institutions make up the largest category of buyers in North America, responsible for nearly half the market in 2025. Pharmaceutical and biotechnology companies account for almost a third as they ramp up drug discovery and biomarker identification using single-cell technologies. Contract research organizations and hospitals are emerging buyers as clinical adoption broadens.
Study Coverage
Metrics
Details
Years
2020-2035
Base Year
2025
Market Size
2450
Regions
United States, Canada, Mexico
Segments
By Type, By Application, By Distribution Channels, By Technology, By Organization Size
June 12, 2024: Thermo Fisher Scientific launched a new microfluidics-based single cell analyzer for rapid genomics and proteomics applications.
July 8, 2024: 10x Genomics unveiled the Chromium X Expansion Kit, accelerating multi-omic single cell workflows for cancer research.
August 2, 2024: NanoString Technologies announced a strategic collaboration with the Dana-Farber Cancer Institute to leverage single cell platforms in immuno-oncology studies.
August 15, 2024: Illumina Inc. upgraded its sequencing system for higher throughput in clinical diagnostics, targeting single cell and rare cell populations.
September 10, 2024: BD introduced a cloud-enabled software suite for automated data analysis across its single-cell instrumentation portfolio.
